Factor VIII Procoagulant and Antigen Content of Antihemophilic Factor (AHF) Concentrates
- 12 November 1978
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 18 (6) , 747-749
- https://doi.org/10.1046/j.1537-2995.1978.18679077961.x
Abstract
Antihemophilic factor concentrates from 6 manufacturers were studied for [human] factor VIII procoagulant and antigen content. Marked lot-to-lot differences were found in the factor VIII antigen:procoagulant ratio. The average antigen content was 2.33 times that of procoagulant activity in 21 lots studied, indicating a significant loss of activity during the fractionation process.This publication has 15 references indexed in Scilit:
- Antihemophilic factor concentrate therapy in von Willebrand disease. Dissociation of bleeding-time factor and ristocetin-cofactor activitiesPublished by American Medical Association (AMA) ,1976
- Failure of AHF concentrate to control bleeding in von Willebrand's diseaseThe American Journal of Medicine, 1976
- Efficacy of Self-Therapy in HemophiliaNew England Journal of Medicine, 1974
- Willebrand Factor and Ristocetin II. RELATIONSHIP BETWEEN WILLEBRAND FACTOR, WILLEBRAND ANTIGEN AND FACTOR‐VIII ACTIVITYBritish Journal of Haematology, 1974
- Transfusion and Gel Filtration Studies in von Willebrand's DiseaseBritish Journal of Haematology, 1974
- Von Willebrand Factor: Dissociation from Antihemophilic Factor Procoagulant ActivityScience, 1973
- ANTIGEN/BIOLOGICAL-ACTIVITY RATIO FOR FACTOR VIIIThe Lancet, 1973
- Studies on the Response of Patients with Classic Hemophilia to Transfusion with Concentrates of Antihemophilic FactorJournal of Clinical Investigation, 1972
- Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand's diseaseJournal of Clinical Investigation, 1971
- RELATIVE STABILITY OF PLASMA ANTIHEMOPHILIC FACTOR (AHF) UNDER DIFFERENT CONDITIONS OF STORAGE*The Lancet Healthy Longevity, 1956